Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21648 | 353 | 29.2 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1714 | 6107 | CIRCULATING TUMOR CELLS//DISSEMINATED TUMOR CELLS//UTEROGLOBIN |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ESTRAMUSTINE BINDING PROTEIN | Author keyword | 51 | 91% | 6% | 21 |
2 | ESTRAMUSTINE | Author keyword | 19 | 34% | 13% | 46 |
3 | ESTROMUSTINE | Author keyword | 6 | 100% | 1% | 4 |
4 | ESTRAMUSTINE PHOSPHATE | Author keyword | 5 | 25% | 5% | 16 |
5 | SALIVARY ANDROGEN BINDING PROTEIN | Author keyword | 2 | 67% | 1% | 2 |
6 | HUMAN PROSTATIC CARCINOMA | Author keyword | 2 | 50% | 1% | 3 |
7 | PROSTATIC BINDING PROTEIN | Author keyword | 2 | 50% | 1% | 3 |
8 | ACT BIOTECH | Address | 1 | 50% | 1% | 2 |
9 | ASSORTATIVE MATE SELECTION BEHAVIOR | Author keyword | 1 | 100% | 1% | 2 |
10 | CYSTATIN RELATED PROTEIN | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHOSPHATE ESTRACYT | 41 | 90% | 5% | 18 |
2 | EMBP | 26 | 100% | 3% | 11 |
3 | BINDING PROTEIN EMBP | 12 | 86% | 2% | 6 |
4 | ESTRACYT | 11 | 67% | 3% | 10 |
5 | DU 145 | 10 | 48% | 4% | 15 |
6 | PROSTATIC CANCER PATIENTS | 9 | 83% | 1% | 5 |
7 | UTEROGLOBIN FAMILY | 6 | 80% | 1% | 4 |
8 | FEL DI | 6 | 71% | 1% | 5 |
9 | ESTRAMUSTINE BINDING PROTEIN | 5 | 63% | 1% | 5 |
10 | MAJOR PROTEIN | 3 | 12% | 6% | 22 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Pharmacokinetics and pharmacodynamics of estramustine phosphate | 1998 | 14 | 50 | 96% |
Estramustine in malignant glioma | 1996 | 4 | 42 | 86% |
Estramustine resistance | 1999 | 6 | 54 | 46% |
A short review of analytical methods for the determination of estramustine phosphate and its metabolites in biological samples | 2005 | 0 | 34 | 62% |
PRECLINICAL AND CLINICAL PERSPECTIVES ON THE USE OF ESTRAMUSTINE AS AN ANTIMITOTIC DRUG | 1992 | 20 | 51 | 41% |
ESTRAMUSTINE - A NITROGEN-MUSTARD STEROID WITH ANTIMICROTUBULE ACTIVITY | 1989 | 25 | 43 | 40% |
A novel strategy for growth suppression of glioma cells: Targeting microtubules | 2004 | 0 | 41 | 24% |
IMPORTANCE OF THE THIOL DISULFIDE STATUS OF MICROTUBULE PROTEINS FOR ANTIMITOTIC DRUG-ACTION | 1988 | 5 | 26 | 23% |
ENDOCRINE THERAPY FOR ADVANCED PROSTATIC-CANCER | 1985 | 0 | 3 | 33% |
TREATMENT OF ADVANCED-CARCINOMA OF THE PROSTATE WITH ESTRAMUSTIN PHOSPHATE - REVIEW OF THE LITERATURE AND OWN RESULTS | 1983 | 5 | 5 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ACT BIOTECH | 1 | 50% | 0.6% | 2 |
2 | CELL MOL PHARMACOL EXPTL THER EUT | 1 | 50% | 0.3% | 1 |
3 | MEDHERBERT IRVING COMPREHENS CANC | 0 | 33% | 0.3% | 1 |
4 | WALLENBERG TUMOR IMMUNOL | 0 | 33% | 0.3% | 1 |
5 | MOL PHARMACOL RADIOBIOL | 0 | 12% | 0.8% | 3 |
6 | BIOANAL ISOTOPE CHEM PHARMACOKINET | 0 | 100% | 0.3% | 1 |
7 | DON MONTI MED | 0 | 100% | 0.3% | 1 |
8 | DON MONTI N SHORE UNIV HOSP | 0 | 100% | 0.3% | 1 |
9 | GRP PFIZER INC | 0 | 100% | 0.3% | 1 |
10 | ISOTOPE ELLING S | 0 | 100% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000200273 | MAMMAGLOBIN//MAMMAGLOBIN A//HUMAN MAMMAGLOBIN |
2 | 0.0000143237 | FOSFESTROL//IDIOPATHIC URETHRITIS//5 ALPHA ANDROSTANEDIOL |
3 | 0.0000134510 | ABIRATERONE//ENZALUTAMIDE//CASTRATION RESISTANT PROSTATE CANCER |
4 | 0.0000109540 | MUS GENUS//KIDNEY ANDROGEN REGULATED PROTEIN//RENAL INDUCTION |
5 | 0.0000109256 | MICROTUBULE ASSOCIATED PROTEIN 1B//MAP1B//MAP1A |
6 | 0.0000096502 | UTEROGLOBIN//CC10//CLARA CELL 10 KDA PROTEIN |
7 | 0.0000090429 | HOMO AZA STEROIDAL ESTERS//STEROIDAL ESTERS//HOMO AZA STEROIDS |
8 | 0.0000090295 | PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL |
9 | 0.0000072783 | EPPIN//PROTEIN SV IV//SEMENOGELIN |
10 | 0.0000047345 | INTERMEDIARY METABOLISM ENZYMES//NEUROSCI DOCTORAL SUBPROGRAM//AURON MISHEIL THERAPY |